Notification #289
2025-08-21 17:36:38
EQL Pharma AB
First Time
Basic Information
- Subject
- Alexander Brising
- Subject Person
- Alexander Brising
- Position
- Annan medlem i bolagets administrations-, lednings- eller kontrollorgan
- LEI
- 549300Q8B2D2AE8GCW21
Additional Details
- Closely Associated
- No
- Linked to Program
- No
Transaction Summary
Transactions
EQL Pharma
SE0005497732
Aktie
Transaction
Avyttring
Price86,24 kr
Volume7 402
Total Value638 348,48 kr
Date2025-08-18 00:00:00
PlaceNASDAQ STOCKHOLM AB
EQL Pharma
SE0005497732
Aktie
Transaction
Avyttring
Price86,07 kr
Volume2 054
Total Value176 787,78 kr
Date2025-08-19 00:00:00
PlaceNASDAQ STOCKHOLM AB
EQL Pharma
SE0005497732
Aktie
Transaction
Avyttring
Price84,08 kr
Volume5 528
Total Value464 794,24 kr
Date2025-08-20 00:00:00
PlaceNASDAQ STOCKHOLM AB
| Date & Time | Instrument | Type | Transaction | Price | Volume | Value | Place |
|---|---|---|---|---|---|---|---|
| 2025-08-18 00:00:00 | EQL Pharma SE0005497732 | Aktie | Avyttring | 86,24 kr | 7 402 | 638 348,48 kr | NASDAQ STOCKHOLM AB |
| 2025-08-19 00:00:00 | EQL Pharma SE0005497732 | Aktie | Avyttring | 86,07 kr | 2 054 | 176 787,78 kr | NASDAQ STOCKHOLM AB |
| 2025-08-20 00:00:00 | EQL Pharma SE0005497732 | Aktie | Avyttring | 84,08 kr | 5 528 | 464 794,24 kr | NASDAQ STOCKHOLM AB |